文献速递心血管CT

用于冠状动脉CT血管成像冠状动脉管腔强化一致性优化的测试团注对比剂注射方案

An Optimized Test Bolus Contrast Injection Protocol for Consistent Coronary Artery Luminal Enhancement for Coronary CT Angiography.
PubMed 文献 · Acad Radiol · 2019-05-30

研究前瞻性比较标准测试团注方案、优化测试团注方案与按体重注射方案在冠状动脉CT血管成像中的冠状动脉强化一致性。优化测试团注方案冠状动脉强化变异百分比标准差为10.5%,低于按体重方案的25.3%和标准测试团注方案的27.1%(p<0.0001),且落入预设强化范围的比例最高(88%,p=0.002)。

要点

  • 优化测试团注方案冠状动脉强化变异百分比标准差为10.5%,低于按体重方案的25.3%和标准测试团注方案的27.1%(p<0.0001)。
  • 优化测试团注方案落入预设冠状动脉强化范围(325-500 HU)的比例为88%(p=0.002)。
  • 优化测试团注方案对比剂注射时机最佳者占73%,按体重方案仅22%(p<0.0001)。

核心结论

  • 与按体重注射方案相比,优化测试团注引导注射方案使冠状动脉CT血管成像冠状动脉强化的变异明显减小。

研究设计与样本

  • 前瞻性研究,标准测试团注方案32例、优化测试团注方案59例、按体重注射方案60例;测试团注为稀释对比剂(20%-30%碘帕醇370与生理盐水混合),测量主动脉峰值强化并计算CCTA专用水/对比剂混合液。

诊断标准与关键数值

  • 预设冠状动脉强化适宜范围为325-500 HU;优化测试团注方案落入该范围的比例为88%(p=0.002);以最大升主动脉强化判定注射时机最佳,优化测试团注方案73% vs 按体重方案22%(p<0.0001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Consistent levels of coronary artery enhancement are essential for quantitative analysis of coronary artery plaque. We studied three contrast injection protocols for coronary CT angiography (CCTA) and compared mean attenuation level and consistency of vascular contrast enhancement. We hypothesized that test bolus adjusted protocols will have a superior consistency of coronary attenuation compared to a weight-based protocol.

MATERIALS AND METHODS: We prospectively evaluated a standard test bolus injection protocol (protocol 1, 32 subjects) and an optimized test bolus injection protocol (protocol 2, 59 subjects) in comparison to a body weight-based injection protocol (60 subjects). The test bolus was diluted contrast (20%-30% iopamidol 370 mixed with normal saline); peak aortic attenuation was measured and used to calculate a specific water/contrast mixture for the CCTA. The mean attenuation of the coronary lumen was measured on CCTA. Metrics of optimum arterial enhancement included the percentage of patients within a predetermined range for coronary attenuation (325-500 HU) and optimal timing with maximal ascending aortic attenuation. In addition, interpatient variation in coronary enhancement was quantified as percentage standard deviation of the attenuation.

RESULTS: The mean attenuation of the coronary arteries was similar in all protocols (362, 364, and 375 HU for the weight-based, test bolus 1 and 2 protocols, respectively). The percentage standard deviations of the weight-based, test bolus 1 and 2 protocols for coronary attenuation were 25.3%, 27.1%, and 10.5%, respectively (p < 0.0001). Test optimized bolus protocol 2 yielded the highest percentage of scans within the preferred coronary attenuation range (88%, p = 0.002). In test bolus protocol 2, the contrast timing was optimal in 73% of cases compared to only 22% of cases in the body mass guided injection protocol (protocol 1, p < 0.0001).

CONCLUSION: An optimized test bolus guided injection protocol resulted in a marked reduction in variation in coronary enhancement for CCTA compared to a body weight-based injection protocol.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Sandfort V, Choi Y, Symons R, et al. An Optimized Test Bolus Contrast Injection Protocol for Consistent Coronary Artery Luminal Enhancement for Coronary CT Angiography. Acad Radiol. 2019. PMID: 31155485. doi:10.1016/j.acra.2019.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。